Cargando…
Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis
BACKGROUND: Several anti-D immunoglobulin strategies exist for preventing Rh hemolytic disease of the fetus and newborn. This study systematically assessed the clinical value of those therapeutic strategies. METHODS: The Web of Science, PubMed, EMBASE, China National Knowledge Infrastructure (CNKI)...
Autores principales: | Xie, Xiaohui, Fu, Qiurong, Bao, Ziwei, Zhang, Yi, Zhou, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067404/ https://www.ncbi.nlm.nih.gov/pubmed/32163467 http://dx.doi.org/10.1371/journal.pone.0230073 |
Ejemplares similares
-
Hemolytic disease of fetus and newborn due to anti-E alloantibody in a newborn of Rh (D)-positive mother
por: Kumawat, Vijay, et al.
Publicado: (2012) -
Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti‐D was incorrectly identified as RhIG
por: Walhof, Mackenzie L., et al.
Publicado: (2022) -
Hemolytic disease of the fetus and newborn caused by anti-E
por: Usman, Adiyyatu Sa’idu, et al.
Publicado: (2013) -
Severe Hemolytic Disease of Fetus and Newborn Due to Anti-S Antibodies
por: Reddy, Vudum Sridhar, et al.
Publicado: (2014) -
Hemolytic Disease of the Fetus and Newborn Due to Anti-Gonzales Antibody
por: Fives, Kaila R, et al.
Publicado: (2023)